WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Jazz Pharmaceuticals earnings were -$404.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest JAZZ earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$718.5M, up 676.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, JAZZ reported annual earnings of $560.1M, with 35% growth.

JAZZ earnings history

Current Revenue
$4.1B
Current Earnings
-$404.8M
Current Profit Margin
-9.9%

JAZZ Return on Equity

Current Company
-10%
Current Industry
-9.6%
Current Market
32.2%
JAZZ's Return on Equity (-10%)... subscribe to Premium to read more.
High Return on Equity Performance

JAZZ undefined

Current Company
-3.5%
Current Industry
0%
JAZZ is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when JAZZ announces earnings.

JAZZ undefined

Current Company
-3.4%
Current Industry
7.7%
JAZZ's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

JAZZ vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
JAZZ$371.29M-$404.84MN/A-$6.63
CORT$102.16M$131.98M+4.94%$1.26
RVMD-$798.13M-$812.06MN/A-$4.51
ROIV-$432.28M-$490.63MN/A-$0.70
RYTM-$159.64M-$188.40MN/A-$3.01
View Top Biotech Stocks

Jazz Pharmaceuticals Earnings Reports & History FAQ

What were Jazz Pharmaceuticals's earnings last quarter?

On JAZZ's earnings call on Invalid Date, Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q2 2025 earnings per share (EPS) of -$11.74, up 538.06% year over year. Total JAZZ earnings for the quarter were -$718.47 million. In the same quarter last year, Jazz Pharmaceuticals's earnings per share (EPS) was $2.68.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.

Is Jazz Pharmaceuticals profitable or losing money?

As of the last Jazz Pharmaceuticals earnings report, Jazz Pharmaceuticals is currently losing money. Jazz Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$404.84 million, a 202.51% decrease year over year.

What was JAZZ's earnings growth in the past year?

As of Jazz Pharmaceuticals's earnings date in Invalid Date, Jazz Pharmaceuticals's earnings has grown year over year. JAZZ earnings in the past year totalled -$404.84 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.